The cluster of open-market purchases by the CEO, CFO, and a director within a one-week window is a rare and strong vote of confidence. Monitor for upcoming catalysts such as clinical trial data or partnership announcements that may have prompted this buying.
Price Chart
Executive Summary
Three insiders at Tenax Therapeutics, including the CEO and CFO, made open-market purchases totaling $122K over a one-week window. This cluster of insider buying, particularly with C-suite participation, is a bullish signal suggesting confidence in the company's near-term prospects.
Key Financial Metrics
Key Facts
- CEO Christopher Thomas Giordano purchased 4,850 shares at $1.82 on 2026-09-15.
- CFO Thomas R. Staab II purchased 5,700 shares at $1.94 on 2026-09-11.
- Director Declan Doogan purchased 53,000 shares at $1.92 on 2026-09-16.
- Total insider purchases: $122K, all open-market (code P).
- No insider sales were reported in the cluster window.
Financial Impact
Total insider purchases of $122K represent approximately 0.04% of the company's market cap (based on a $326M market cap from prior snapshot), which is below the 0.1% materiality threshold. However, the cluster of C-suite and director open-market buys is a strong qualitative signal.
Risk Factors
- The total dollar value ($122K) is small relative to market cap, limiting the financial materiality.
- Insider buying can be a leading signal but does not guarantee near-term stock appreciation.
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TENX-1789695051820 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | SC 13G/A | $1.62 | awaiting T+5 | — | $1.72 (+6.17%) |
Oct 15, 2026 12d ago | SC 13G/A | $1.36 $1.72 | ▲ +26.47% | ▲ +26.90% | $1.72 (+26.47%) |
Oct 13, 2026 14d ago | SC 13G/A | $1.60 $1.63 | ▲ +1.88% | ▲ +3.03% | $1.72 (+7.50%) |
Oct 9, 2026 18d ago | SC 13G/A | $1.83 $1.52 | ▼ −16.94% | ▼ −15.45% | $1.72 (−6.01%) |
Oct 8, 2026 19d ago | 8-K | $1.87 $1.36 | ▼ −27.27% | ▼ −25.30% | $1.72 (−8.02%) |
Sep 17, 2026 5w ago | Insider Cluster | $1.90 $1.81 | ▼ −4.74% | ▼ −6.01% | $1.72 (−9.47%) |
Sep 9, 2026 6w ago | 8-K | $2.13 $1.82 | ▼ −14.55% | ▼ −13.90% | $1.72 (−19.25%) |
Aug 29, 2026 8w ago | Press Release | $1.84 $2.05 | ▲ +11.20% | ▲ +11.34% | $1.72 (−6.52%) |
Aug 10, 2026 11w ago | 8-K | $1.38 $1.71 | ▲ +24.36% | ▲ +24.41% | $1.72 (+25.09%) |
Aug 10, 2026 11w ago | Press Release | $1.38 $1.71 | ▲ +24.36% | ▲ +24.41% | $1.72 (+25.09%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers